SFT2D1 and familial pancreatic carcinoma: For example, recent studies have linked SFT2D1 to tumor progression and immune modulation in cervical and pancreatic cancers (Kang et al., 2024; Liu D. et al., 2023), including associations with alternative splicing events and cellular transport pathways.